NOT-OD-23-169: Notice of Pre-Application and FAQs for RFA-OD-23-021, Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)

Notice of Pre-Application and FAQs for RFA-OD-23-021, Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)

Notice Number:

NOT-OD-23-169

Key Dates

Release Date:

Related Announcements

August 2, 2023 - Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required). See NOFO RFA-OD-23-021.

Issued by

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

Purpose

This Notice is to inform prospective applicants about the pre-application webinar for the Notice of Funding Opportunity (NOFO) RFA-OD-23-021 “Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)” and the availability of a Frequently Asked Questions (FAQ) document.

Webinar Information

Date: Tuesday, September 12, 2023

Time: 12:00 p.m. to 1:30 p.m. (Eastern Time)

NIH and FDA staff will provide an overview of RFA-OD-23-021, the application review process, and answer questions from prospective applicants. The webinar is open to all prospective applicants, and participation in the webinar is not a prerequisite to applying. All interested individuals are encouraged to register in advance to attend the webinar.

The webinar registration link is https://nih.zoomgov.com/meeting/register/vJItdeitqzwjHXTUf1KIYqFqyf8bbKh9lz0. Additional information about the webinar can be found on the pre-application webinar page. The webinar will be captioned in real-time. Individuals needing reasonable accommodations should contact [email protected]. Requests should be made at least five business days before the event. After the webinar, webinar slides and a captioned copy of the event will be posted on the pre-application webinar page.

Prospective applicants are encouraged to register and submit questions regarding the NOFO in advance of the webinar to [email protected] by September 6, 2023, by 5:00 p.m. ET. While an effort will be made to include all questions in the webinar, presentations, or discussion, it is possible all may not be addressed during the meeting due to time constraints.

Frequently Asked Questions (FAQ)

A Frequently Asked Questions (FAQ) document to address common questions from potential applicants regarding the NOFO is available at https://prevention.nih.gov/tobacco-regulatory-research/funding-opportunities/frequently-asked-questions-public-health-communication-messaging-about-continuum-risk-tobacco.The FAQs may be subsequently updated without notice. Prospective applicants are encouraged to visit this site often.

Inquiries

Please direct all inquiries about the pre-application webinar to:

Tobacco Regulatory Science Program (TRSP)
Office of Disease Prevention
Telephone: 301-451-7464
Email:[email protected]

Please direct all inquiries about the U01 NOFO to scientific contact:

Maria Roditis, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-5326
Email: [email protected]